These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 10400405

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients.
    Wolffenbuttel BH, Gomis R, Squatrito S, Jones NP, Patwardhan RN.
    Diabet Med; 2000 Jan; 17(1):40-7. PubMed ID: 10691158
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A review of rosiglitazone in type 2 diabetes mellitus.
    Werner AL, Travaglini MT.
    Pharmacotherapy; 2001 Sep; 21(9):1082-99. PubMed ID: 11560198
    [Abstract] [Full Text] [Related]

  • 8. Rosiglitazone.
    Wolffenbuttel BH, Sels JP, Huijberts MS.
    Expert Opin Pharmacother; 2001 Mar; 2(3):467-78. PubMed ID: 11336599
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review.
    Malinowski JM, Bolesta S.
    Clin Ther; 2000 Oct; 22(10):1151-68; discussion 1149-50. PubMed ID: 11110228
    [Abstract] [Full Text] [Related]

  • 14. Promising new approaches.
    Reasner CA.
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [Abstract] [Full Text] [Related]

  • 15. [The thiazolidinedione derivates: a new class of oral blood glucose lowering agents].
    Jazet IM, Meinders AE.
    Ned Tijdschr Geneeskd; 2001 Aug 11; 145(32):1541-7. PubMed ID: 11525086
    [Abstract] [Full Text] [Related]

  • 16. Hepatotoxicity with thiazolidinediones: is it a class effect?
    Scheen AJ.
    Drug Saf; 2001 Aug 11; 24(12):873-88. PubMed ID: 11735645
    [Abstract] [Full Text] [Related]

  • 17. [Rosiglitazone(BRL-49653)].
    Yonezawa N, Oka Y.
    Nihon Rinsho; 2001 Nov 11; 59(11):2195-9. PubMed ID: 11712407
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Troglitazone, an insulin action enhancer, improves glycaemic control and insulin sensitivity in elderly type 2 diabetic patients.
    Kumar S, Prange A, Schulze J, Lettis S, Barnett AH.
    Diabet Med; 1998 Sep 11; 15(9):772-9. PubMed ID: 9737807
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.